339 related articles for article (PubMed ID: 16501902)
1. Infection with human herpesvirus type 8 and Kaposi's sarcoma in Sardinia.
Serraino D; Cerimele D; Piselli P; Aztori L; Farchi F; Carletti F; Navarra A; Masala MV; Rezza G
Infection; 2006 Feb; 34(1):39-42. PubMed ID: 16501902
[TBL] [Abstract][Full Text] [Related]
2. Infection with human herpesvirus type 8 and kaposi's sarcoma in a central Italian area formerly endemic for malaria.
Serraino D; Corona RM; Giuliani M; Farchi F; Sarmati L; Uccella I; Andreoni M; Rezza G
Infection; 2003 Jan; 31(1):47-50. PubMed ID: 12590333
[TBL] [Abstract][Full Text] [Related]
3. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy.
Valdarchi C; Serraino D; Cordiali Fei P; Castilletti C; Trento E; Farchi F; Rezza G;
Infection; 2007 Feb; 35(1):22-5. PubMed ID: 17297585
[TBL] [Abstract][Full Text] [Related]
4. Prevalence, incidence and correlates of HHV-8/KSHV infection and Kaposi's sarcoma in renal and liver transplant recipients.
Andreoni M; Goletti D; Pezzotti P; Pozzetto A; Monini P; Sarmati L; Farchi F; Tisone G; Piazza A; Pisani F; Angelico M; Leone P; Citterio F; Ensoli B; Rezza G
J Infect; 2001 Oct; 43(3):195-9. PubMed ID: 11798259
[TBL] [Abstract][Full Text] [Related]
5. Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcoma.
Tanzi E; Zappa A; Caramaschi F; Amendola A; Lasagna D; Gatti L; Ascoli V; Rezza G; Zanetti AR
J Med Virol; 2005 Aug; 76(4):571-5. PubMed ID: 15977229
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten County, Sweden.
Tedeschi R; Bidoli E; Agren A; Hallmans G; Wadell G; De Paoli P; Dillner J
J Med Virol; 2006 Mar; 78(3):372-8. PubMed ID: 16419115
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Kaposi's sarcoma-associated herpesvirus in healthy adults in Israel.
Iscovich J; Fischbein A; Fisher-Fischbein J; Freedman LS; Eng SM; Boffetta P; Vudovich A; Glasman C; Goldschmidt R; Livingston M; Heger-Maslansky B; Brennan P; Moore PS
Anticancer Res; 2000; 20(3B):2119-22. PubMed ID: 10928163
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy.
Calabrò ML; Sheldon J; Favero A; Simpson GR; Fiore JR; Gomes E; Angarano G; Chieco-Bianchi L; Schulz TF
J Hum Virol; 1998; 1(3):207-13. PubMed ID: 10195244
[TBL] [Abstract][Full Text] [Related]
9. Classic kaposi sarcoma: epidemiology and risk factors.
Iscovich J; Boffetta P; Franceschi S; Azizi E; Sarid R
Cancer; 2000 Feb; 88(3):500-17. PubMed ID: 10649240
[TBL] [Abstract][Full Text] [Related]
10. Asymmetrical transmission of human herpesvirus 8 among spouses of patients with Kaposi sarcoma.
Dupuy A; Schulz T; Chevret S; Agbalika F; Pellet C; Janier M; Dupin N; Vérola O; Calvo F; Lebbé C
Br J Dermatol; 2009 Mar; 160(3):540-5. PubMed ID: 19077076
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease.
Mohanna S; Maco V; Bravo F; Gotuzzo E
Int J Infect Dis; 2005 Sep; 9(5):239-50. PubMed ID: 16095940
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
[TBL] [Abstract][Full Text] [Related]
13. Human herpesvirus-8 infection and Kaposi's sarcoma after liver and kidney transplantation in different geographical areas of Spain.
García-Astudillo LA; Leyva-Cobián F
Transpl Immunol; 2006 Dec; 17(1):65-9. PubMed ID: 17157220
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of human herpesvirus 8 DNA sequences in human immunodeficiency virus-negative individuals without Kaposi's sarcoma in Greece.
Zavos G; Gazouli M; Papaconstantinou I; Lukas JC; Zografidis A; Kostakis A; Nasioulas G
In Vivo; 2005; 19(4):729-32. PubMed ID: 15999541
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases.
Rezza G; Andreoni M; Dorrucci M; Pezzotti P; Monini P; Zerboni R; Salassa B; Colangeli V; Sarmati L; Nicastri E; Barbanera M; Pristerà R; Aiuti F; Ortona L; Ensoli B
J Natl Cancer Inst; 1999 Sep; 91(17):1468-74. PubMed ID: 10469747
[TBL] [Abstract][Full Text] [Related]
16. Serum HHV8 DNA and Tat antibodies in Kaposi's sarcoma patients with and without HIV-1 infection.
Massambu C; Pyakurel P; Kaaya E; Enbom M; Urassa W; Demirhan I; Loewer J; Linde A; Chandra A; Heiden T; Doerr HW; Chandra P; Biberfeld P
Anticancer Res; 2003; 23(3B):2389-95. PubMed ID: 12894519
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus infection and multiple myeloma.
Cottoni F; Uccini S
Science; 1997 Dec; 278(5345):1972; author reply 1972-3. PubMed ID: 9417646
[No Abstract] [Full Text] [Related]
18. The role of human herpesvirus 8 in the pathogenesis of Kaposi's sarcoma.
Blauvelt A
Adv Dermatol; 1999; 14():167-206; discussion 207. PubMed ID: 10643499
[TBL] [Abstract][Full Text] [Related]
19. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.
Sirianni MC; Vincenzi L; Topino S; Giovannetti A; Mazzetta F; Libi F; Scaramuzzi D; Andreoni M; Pinter E; Baccarini S; Rezza G; Monini P; Ensoli B
Eur J Immunol; 2002 Oct; 32(10):2711-20. PubMed ID: 12355422
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
